BUB1 and lung carcinoma: In this study, we found that the expression of BUB1, CCNA2, CDC20 and KIF11 increased after inhibitor resistance compared with inhibitor-sensitive lung cancer samples, and these targets were associate with cell cycle, cell proliferation, DNA damage and EMT.